- Home
- XCUR vs MODD Comparison
XCUR vs MODD Comparison
Compare XCUR & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- MODD
- Stock Information
- Founded
- XCUR 2011
- MODD 1998
- Country
- XCUR United States
- MODD United States
- Employees
- XCUR N/A
- MODD N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- XCUR Health Care
- MODD Health Care
- Exchange
- XCUR Nasdaq
- MODD Nasdaq
- Market Cap
- XCUR 46.0M
- MODD 46.3M
- IPO Year
- XCUR N/A
- MODD N/A
- Fundamental
- Price
- XCUR $7.13
- MODD $0.72
- Analyst Decision
- XCUR
- MODD
- Analyst Count
- XCUR 0
- MODD 0
- Target Price
- XCUR N/A
- MODD N/A
- AVG Volume (30 Days)
- XCUR 57.8K
- MODD 93.9K
- Earning Date
- XCUR 08-12-2025
- MODD 08-13-2025
- Dividend Yield
- XCUR N/A
- MODD N/A
- EPS Growth
- XCUR N/A
- MODD N/A
- EPS
- XCUR N/A
- MODD N/A
- Revenue
- XCUR N/A
- MODD N/A
- Revenue This Year
- XCUR N/A
- MODD N/A
- Revenue Next Year
- XCUR N/A
- MODD N/A
- P/E Ratio
- XCUR N/A
- MODD N/A
- Revenue Growth
- XCUR N/A
- MODD N/A
- 52 Week Low
- XCUR $1.44
- MODD $0.63
- 52 Week High
- XCUR $36.00
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- XCUR 46.65
- MODD 47.67
- Support Level
- XCUR $6.52
- MODD $0.69
- Resistance Level
- XCUR $9.50
- MODD $0.75
- Average True Range (ATR)
- XCUR 0.78
- MODD 0.05
- MACD
- XCUR -0.01
- MODD 0.01
- Stochastic Oscillator
- XCUR 28.83
- MODD 46.67
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.